Dr. Igor Orshanskiy joined as Head of Business Development in November 2023. He has over 12 years of experience in Business Development in small and big pharmaceutical and biotech companies. He has previously held the position of Head of Business Development at AiCuris Anti-infecitve Cures AG, before that worked at Bayer AG in the Business Development & Licensing and External Innovaiton & Alliances roles. Before Bayer he worked as a CEO of a biotech company NewVac, being responsible for corporate strategy and business development activities.
He holds a Ph.D in molecular modelling from the Moscow State University.